Not Signed In - Relate
Crohn's disease; Crohn//'s disease; Inflamatory Bowel Disease; Inflammatory Bowel Disease, Crohn's |
Remicade | |
|
Crohn's disease causes inflammation in the small intestine. Crohn's disease usually occurs in the lower part of the small intestine, called the ileum, but it can affect any part of the digestive tract, from the mouth to the anus. The inflammation extends deep into the lining of the affected organ. The inflammation can cause pain and can make the intestines empty frequently, resulting in diarrhea. Crohn's disease is an inflammatory bowel disease (IBD), the general name for diseases that cau... 
|
A monoclonal antibody that blocks the action of a cytokine called tumor necrosis factor alfa. It is being studied in the treatment and prevention of weight loss and loss of appetite in patients with advanced cancer. It belongs to the family of drugs called monoclonal antibodies.
|
Crohn's Disease as related to Infliximab
- Crohn's disease - infliximab
The summary for the published technology appraisal on using infliximab in the treatment of severe Crohn?s disease It links to the published guidance and key documents.
- Crohn's disease - infliximab (review) and adalimumab
Use of tumour necrosis factor alpha (TNF a) inhibitors (adalimumab, and infliximab [review]) for Crohn's disease
- Crohn's disease - Wikipedia, the free encyclopedia
Crohn's disease (also known as regional enteritis ) is a chronic , episodic, inflammatory bowel ... 6-MP), and methotrexate ), and newer biological medications, such as infliximab (Remicade ...
- Infliximab for Crohn's disease
Drug details for Infliximab for Crohn's disease. ... How It Works. A tumor necrosis factor (TNF) antagonist is a type of antibody that inhibits tumor necrosis factor, a protein ...
- Infliximab in Crohn's disease
UpToDate, electronic clinical resource tool for physicians and patients that provides information on Adult Primary Care and Internal Medicine, Allergy and Immunology ...
- Crohn's Disease in the UK
Infliximab (RemicadeThis information sheet is relevant to the United Kingdom ) Anti TNF a monoclonal antibody is a new type of drug for treating Crohn's Disease, which aims to ...
- Long-term Remission of Crohn's Disease Using Infliximab Without Human ...
PRACTICAL GASTROENTEROLOGY • APRIL 2006 106 Long-term Remission of Crohn's Disease Using Infliximab Without Human Anti-chimeric Antibody (HACA) in Absence of Anti-metabolites: A ...
- CCFA.org: About Crohn's Disease
Biologic therapies. In August 1998, the FDA approved the first biologic therapy for Crohn's disease. This was infliximab (Remicade®), which is indicated for moderately to ...
- Adult Crohn's Disease and Remicade
REMICADE. (infliximab) has been proven to reduce the signs and symptoms of Crohn's disease and is the is the first and only treatment approved for moderate to severe Crohn's ...
- MedlinePlus Medical Encyclopedia: Crohn's disease
... be prescribed for abscesses or fistulas. Biologic therapy is used to treat patients with severe Crohn's disease that does not respond to any other types of medication. Infliximab ...
email this page
print this page
bookmark this page
feedback on this page
